Skip to main navigation
Skip to search
Skip to main content
12th Annual Florey Postgraduate Conference
Acute Lymphoblastic Leukamia (ALL) Research Group
Tavakoli PS, Eadie LN, Heatley SL, White DW.
The dual SYK/JAK inhibitor cerdulatinib demonstrates in vitro efficacy against a novel MYB-TYK2 fusion protein in acute lymphoblastic leukaemia cells.
Adelaide, South Australia
25 Sep 2018